(5Z,8Z,11Z,14Z)-N-Cyclopropyl-5,8,11,14-eicosatetraenamide

(5Z,8Z,11Z,14Z)-N-Cyclopropyl-5,8,11,14-eicosatetraenamide Basic Attributes

Characteristics

Safety Information

Drug Information

(5Z,8Z,11Z,14Z)-N-Cyclopropyl-5,8,11,14-eicosatetraenamide Use and Manufacturing

Computed Properties

Learn More Other Chemicals

• 10-hydroxy-10-(3-octa-2,5-dienyloxiran-2-yl)deca-5,8-dienoic acid

  103188-12-1

• (5E,9E)-8-hydroxy-10-[3-[(2E,5E)-octa-2,5-dienyl]oxiran-2-yl]deca-5,9-dienoic acid

  103188-13-2

• (4-benzamidophenyl) (Z)-7-[(1R,2R,3R)-3-hydroxy-2-(2-hydroxy-3-phenoxypropoxy)-5-oxocyclopentyl]hept-4-enoate

  106342-69-2

• 20-dimethyl-7-thiaprostaglandin E1 methyl ester Formula

  111037-12-8

• 11-deoxyprostaglandin E1 4-hydroxyphenyl ester Formula

  114495-95-3

• 16,18-ethano-20-ethyl-6-oxoprostaglandin E1 leucinamide Formula

  115288-30-7

• (5S,6Z,8E,10E,12R,14Z)-5,12-Dihydroxy-20-oxo-6,8,10,14-eicosatetraenoic acid Structure

  115609-68-2

• EP 171 Structure

  115825-93-9

• What is 5,12,19-trihydroxyicosa-6,8,10,14-tetraenoic acid

  117605-61-5

• What is (E)-7-[5-chloro-2-[(E)-3-cyclohexyl-3-hydroxyprop-1-enyl]-3-hydroxycyclopentyl]hept-5-enoic acid

  117708-11-9